Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.67 USD | +0.89% | +6.58% | -44.03% |
05-01 | Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration | MT |
05-01 | Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 6.250 | 7.220 | 7.110 |
Spread/Res. | -9.28% | -21.47% | -20.25% |
Spread/Supp. | +8.83% | +8.83% | +6.58% |
Support | 5.210 | 5.210 | 5.320 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- EDIT Stock
- Charts Editas Medicine, Inc.